← Latest Filings

K

Kelly Thomas Patrick

Chief Financial Officer

Open-market buys

1

$560K total

Open-market sells

0

$0 total

Tracking since

Sep 2026

Activity timeline

Open-market buy — $560K

Xenon Pharmaceuticals Inc. · Sep 30, 2026

Open-market trades from the last two years.

Holdings as last reported

225,000 Share Option (Right to Buy) in XENE

Held directly · as of 2025-10-15

30,000 Restricted Share Units in XENE

Held directly · as of 2025-10-15

Companies touched

Xenon Pharmaceuticals Inc.